Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MUC1 based glycolipopeptide vaccine with adjuvant

MUC1 based glycolipopeptide vaccine with adjuvant

US Patent 8329639 · Granted Dec 11, 2012

Estimated economic value: $3,632,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using a bispecific antigen-binding construct targeting HER2 for the t2025
Gut microbiota and treatment of cancer2025
Bismuth-thiol compositions and methods of use2025
Methods of using a bispecific antigen-binding construct targeting HER2 in combin2024
Treatment of HER2 positive cancers2024
Treatment of HER2 positive cancers2023
Gut microbiota and treatment of cancer2023
Bismuth-thiol compositions and methods of use2022
Anti-TIGIT antibodies2022
Treatment of HER2 positive cancers2021
Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates2016
MUC1 based glycolipopeptide vaccine with adjuvant2014